Journal
JOURNAL OF HEPATOLOGY
Volume 67, Issue 3, Pages 619-631Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2017.04.026
Keywords
Bile ducts; Bile canaliculus; Bile secretion; Cholangitis; Cholangiopathies; Primary biliary cholangitis; Primary sclerosing cholangitis
Categories
Funding
- Dr. Falk Pharma GmbH
- Gilead
- Abbvie
Ask authors/readers for more resources
The main trigger for liver injury in acquired cholestatic liver disease remains unclear. However, the accumulation of bile acids (BAs) undoubtedly plays a role. Recent progress in deciphering the pathomechanisms of inborn cholestatic liver diseases, decoding mechanisms of BA-induced cell death, and generating modern BA-derived drugs has improved the understanding of the regulation of BA synthesis and transport. Now is the appropriate time to reassess current knowledge about the specific role of BAs in hepatobiliary injury. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available